FAPESP-Funded USP Study Reveals How Obesity and Inflammation Accelerate Lung Aging

Breakthrough Brazilian Study Links Obesity and Inflammation to Accelerated Lung Aging

A pioneering study funded by the São Paulo Research Foundation (FAPESP) and conducted by researchers at the University of São Paulo's Ribeirão Preto Medical School (FMRP-USP) has revealed that obesity and systemic inflammation significantly hasten lung aging, even in young adults. Published in BMC Pulmonary Medicine on September 30, 2025, the research tracked nearly 900 participants from the Ribeirão Preto Birth Cohort over 12 years, from ages 23-25 to 37-38. Led by pulmonologist Ana Carolina Cunha and coordinated by Professor Elcio Oliveira Vianna, the findings challenge the notion that smoking is the sole driver of premature pulmonary decline, highlighting metabolic factors as key contributors to chronic obstructive pulmonary disease (COPD) risk.

The study's timing is critical amid Brazil's rising obesity rates, where recent Vigitel data from 2024 shows 25.7% of adults obese—a 118% increase since 2006—and overweight affecting 62.6% of the population. With COPD impacting over 15 million Brazilians, primarily those over 40, this USP-led investigation underscores the urgency for preventive strategies rooted in university research excellence.

The Ribeirão Preto Birth Cohort: A Cornerstone of Brazilian Longitudinal Research

Established in 1978/1979, the Ribeirão Preto Birth Cohort follows over 6,000 individuals born in São Paulo state, providing invaluable data for health trends. This FAPESP-supported project at FMRP-USP enabled spirometry tests on 895 non-asthmatic participants at two points, measuring forced expiratory volume in one second (FEV1)—a gold standard for lung function. Exclusion of asthmatics via methacholine challenge ensured focus on subtle declines signaling senescence.

Such cohorts exemplify Brazil's higher education contributions to global science. USP's Department of Medicine and Pediatrics, alongside collaborators from UNAERP and UFMA, demonstrate interdisciplinary prowess. For aspiring researchers, opportunities abound in higher ed research positions at institutions like USP.

Unpacking the Methodology: Precise Tracking of FEV1 Decline

Using standardized Koko pneumotachographs per ATS/ERS guidelines, researchers quantified FEV1 percentage change. Key variables included pack-years smoked, C-reactive protein (CRP) levels (inflammation marker), and body mass index (BMI) variation. Multiple linear regression (R²=0.07, p<0.001) controlled for confounders, revealing robust associations without collinearity issues.

Active smoking showed β=-1.957 (p=0.003), CRP β=-0.765 per mg/dL (p=0.001), and BMI change β=-0.285 per kg/m² (p<0.001). These metrics illuminate early senescence, where 75% exhibited FEV1 fall averaging 5%—beyond normal age-related loss.

Key Findings: Quantified Risks from Smoking, Fat, and Fire

Smoking exacted the heaviest toll at 1.95% FEV1 loss per pack-year, but non-smokers faced peril too. Each BMI unit rise eroded 0.28% function; CRP doubling equated to 0.51-0.76% decline. Combined effects amplified damage, with early COPD hallmarks in under-40s.

• Prevalence: 7.6% smokers in cohort, lower than Brazil's 10-12% adult rate.
• Inflammation: Low-grade CRP elevations from adipose tissue cytokines like IL-6, TNF-α.
• Obesity synergy: Visceral fat fuels senescence via extracellular matrix (ECM) stiffening.

Professor Vianna notes: "Metabolic and inflammatory processes damage lungs subtly over time, priming COPD even sans smoke."

Biological Mechanisms: How Obesity Drives Pulmonary Senescence

Obesity induces adipokine dysregulation—leptin excess, adiponectin deficit—sparking chronic low-grade inflammation. This infiltrates lungs, activating fibroblasts into senescence via p16INK4a, p21 pathways. Senescent cells secrete SASP (IL-6, MMPs), remodeling ECM collagen, reducing elasticity akin to aged lungs.

Inflammation markers like CRP correlate with alveolar macrophage polarization, fibrosis. Reviews (AJP Lung) affirm senescence accumulation impairs regeneration, heightening COPD vulnerability. Brazilian context amplifies: urban pollution synergizes adipose-driven stress.

USP's mechanistic insights pave interventions targeting senolytics or anti-inflammatories. Explore clinical research jobs advancing these frontiers.

Brazil's Obesity Crisis: Alarming Stats Fuel Lung Health Concerns

Vigitel 2024 (released Jan 2026) reports obesity at 25.7% adults (11.8% in 2006), overweight 62.6%. São Paulo mirrors national trends, with youth onset rising. IBGE projects near-30% obesity by 2030, straining SUS amid R$340M Viva Mais Brasil initiative.

Linked comorbidities: diabetes up 135%, hypertension 31%. In Ribeirão Preto cohort, BMI gains tracked metabolic shifts mirroring national surge, underscoring prevention need.

Photo by Samuel Costa Melo on Unsplash

COPD Burden in Brazil: From Subclinical to Systemic Epidemic

PLATINO study estimates 15-19% prevalence >40yo, ~16M affected—4th global death cause. Underdiagnosis hits 87.5% in SP, per GOLD 2026. Obesity-inflammation link explains non-smoker cases (20-30%). Economic toll: billions in hospitalizations, lost productivity.

FMRP-USP's work highlights early intervention via spirometry screening. FAPESP's role in funding such pivotal university cohorts vital for policy.

Global Parallels: Echoes in International Lung Aging Research

Aligns with Bonn University (2025): obesity remodels lung ECM via fibroblasts. US/EU reviews link senescence to IPF/COPD via SASP. Brazil's unique cohort strength: longitudinal young data rare globally.

Mechanisms conserved: obesity-hypoventilation, restrictive pattern evolving obstructive.

Public Health Ramifications and Policy Calls

Urges BMI/CRP screening in at-risk youth, lifestyle interventions. Brazil's SUS could integrate spirometry in check-ups. USP advocates multifactorial DPOC view, beyond antitobacco.

"Inflamação sistêmica danifica pulmões constantement," Vianna warns. Ties to São Paulo higher ed jobs in pulmonology research.

USP and FAPESP: Pillars of Brazilian Biomedical Innovation

FMRP-USP's cohort exemplifies state-funded excellence, training pulmonologists/researchers. FAPESP Grant 2017/21035-8 fueled this, alongside CNPq/CAPES. Careers in professor positions or postdocs await.

Future Horizons: Targeting Senescence for Lung Longevity

Senolytics (dasatinib+quercetin) trials promising. Brazilian follow-ups on cohort eyed for COPD trajectories. Vianna: "Genetic-metabolic interplay key."

Practical Steps: Safeguard Your Lungs from Early Aging

• Maintain BMI <25 via diet/exercise.
• Monitor CRP via annual check-ups.
• Quit smoking; avoid passive exposure.
• Spirometry if symptomatic post-30.
• Anti-inflammatory Mediterranean diet.

Consult pulmonologists trained at USP. Explore higher ed career advice for health sciences.

Photo by KOBU Agency on Unsplash

Conclusion: A Wake-Up Call from Brazilian Science

USP's FAPESP-backed revelation reframes lung health: obesity/inflammation rivals smoke in senescence. With Brazil's epidemics, university-led prevention pivotal. Stay informed via Rate My Professor, pursue higher ed jobs, or university jobs advancing this. Act now for enduring breath.